| abstract |
PROBLEM TO BE SOLVED: To treat vascular endothelial protein tyrosine phosphatase (VE-PTP or VEPTP) or human protein tyrosine phosphatase for treating eye disorders characterized by, for example, vascular instability, angiogenesis, neoangiogenesis, vascular leakage, and edema. -Providing a humanized monoclonal antibody that targets beta (HPTP-β). A compound containing a sequence that is at least 80% identical to a particular amino acid sequence. [Selection diagram] None |